Beone Medicines Ltd.(688235)

287.30-5.17-1.77%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
百济神州有限公司
Industry
医药制造业
Listing Date
2021-12-15
Registered Capital
15万元
Introduction
百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是百悦泽、百泽安、百汇泽、安加维、倍利妥、凯洛斯、萨温珂、凯泽百、普贝希（安维汀生物类似药）、百拓维（注射用戈舍瑞林微球）、泰菲乐（达拉非尼）、迈吉宁（曲美替尼）、维全特（帕唑帕尼）、飞尼妥（依维莫司）、赞可达（塞瑞替尼）。截至本报告期末，公司及其控股子公司拥有的发明专利包括美国发明专利64个、中国发明专利67个、日本发明专利30个、欧洲发明专利15个及其他国家或地区的发明专利135个。
No filings yet

1D
5D
Day
Week
Month

Loading ...

High

295.86

Open

295.00

T/O Rate

1.76%

Low

285.00

Close

292.47

Amplitude

3.71%

Most Discussed

{"pagemeta":{"title":"Beone Medicines Ltd.(688235),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Beone Medicines Ltd.(688235) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Beone Medicines Ltd.,688235,Beone Medicines Ltd.股票,Beone Medicines Ltd.股票老虎,Beone Medicines Ltd.股票老虎国际,Beone Medicines Ltd.行情,Beone Medicines Ltd.股票行情,Beone Medicines Ltd.股价,Beone Medicines Ltd.股市,Beone Medicines Ltd.股票价格,Beone Medicines Ltd.股票交易,Beone Medicines Ltd.股票购买,Beone Medicines Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beone Medicines Ltd.(688235),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Beone Medicines Ltd.(688235) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"fillings","symbol":"688235","data":{"stockData":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"Beone Medicines Ltd.","latestPrice":287.3,"timestamp":1769065200000,"preClose":292.47,"halted":0,"volume":2019062,"delay":0,"changeRate":-0.0177,"floatShares":114999999,"shares":1541000000,"eps":-0.0994,"marketStatus":"Closed","change":-5.17,"latestTime":"01-22 15:00:00","open":295,"high":295.86,"low":285,"amount":583000000,"amplitude":0.0371,"askPrice":287.5,"askSize":12,"bidPrice":287.3,"bidSize":6,"shortable":0,"etf":0,"ttmEps":-0.0994,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769131800000},"marketStatusCode":5,"adr":0,"adjPreClose":292.47,"symbolType":"stock_kcb","openAndCloseTimeList":[[1769045400000,1769052600000],[1769058000000,1769065200000]],"highLimit":321.72,"lowLimit":263.22,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1540677809,"isCdr":false,"pbRate":15.09,"roa":"--","roe":"4.26%","epsLYR":-3.64,"committee":-0.132075,"marketValue":442637000000,"turnoverRate":0.0175,"status":1,"afterMarket":{"amount":0,"volume":0,"close":287.3,"buyVolume":0,"sellVolume":0,"time":1769067237919,"indexStatus":"Closed 01-22 15:30:00","preClose":292.47},"hkstockBrief":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"BEIGENE","latestPrice":199.8,"timestamp":1769069298006,"preClose":200.6,"halted":0,"volume":3218903,"delay":0,"premium":"-37.87"},"floatMarketCap":33055000000},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":null,"aProfile":{"ret":0,"listingDate":"2021-12-15","address":"c/oBeOneMedicinesIGmbH,Aeschengraben27,4051Basel,Switzerland","stockEarnings":[{"period":"1week","weight":-0.0642},{"period":"1month","weight":0.0378},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.2232},{"period":"1year","weight":0.5108},{"period":"ytd","weight":0.0696}],"companyName":"百济神州有限公司","boardCode":"AI0027","perCapita":"3195股","boardName":"医药制造业","registeredCapital":"15万元","compareEarnings":[{"period":"1week","weight":0.0024},{"period":"1month","weight":0.0517},{"period":"3month","weight":0.0436},{"period":"6month","weight":0.1472},{"period":"1year","weight":0.2828},{"period":"ytd","weight":0.0387}],"survey":"　　百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是百悦泽、百泽安、百汇泽、安加维、倍利妥、凯洛斯、萨温珂、凯泽百、普贝希（安维汀生物类似药）、百拓维（注射用戈舍瑞林微球）、泰菲乐（达拉非尼）、迈吉宁（曲美替尼）、维全特（帕唑帕尼）、飞尼妥（依维莫司）、赞可达（塞瑞替尼）。截至本报告期末，公司及其控股子公司拥有的发明专利包括美国发明专利64个、中国发明专利67个、日本发明专利30个、欧洲发明专利15个及其他国家或地区的发明专利135个。","serverTime":1769124284896,"listedPrice":192.6,"stockholders":"36008人(较上一季度增加55.74%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}}}}}